31 institutions reported holding $32.6M of XILIO THERAPEUTICS INC (XLO) in SEC 13F filings for 2026-06-30. Largest institutional holders: Bain Capital Life Sciences Investors, LLC ($6.4M), GILEAD SCIENCES, INC. ($6.2M), ORBIMED ADVISORS LLC ($5.7M), Frazier Life Sciences Management, L.P. ($4.0M), Stonepine Capital Management, LLC ($2.2M). Source: SEC Form 13F.
来源:SEC 13F 申报文件 · 截至 2026-06-30